Stuart Keller

Efficacy and safety of ixekizumab in a phase <scp>III</scp> , randomized, double‐blind, placebo‐controlled study in paediatric patients with moderate‐to‐severe plaque psoriasis ( <scp>IXORA</scp> ‐ <scp>PEDS</scp> )

Amy S. Paller, Marieke M.B. Seyger, Gabriel A. Magariños et al. · British Journal of Dermatology · 2020 · 108 citations · Full text

Medicine, Dermatology, Pharmacotherapy +11

Sex‐related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: Results from the PROMETHEUS study

Jaya Chandrasekhar, Usman Baber, Samantha Sartori et al. · Catheterization and Cardiovascular Interventions · 2016 · 70 citations

Medicine, Cardiology, Internal Medicine +15

Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

Usman Baber, Jaya Chandrasekhar, Samantha Sartori et al. · JACC: Cardiovascular Interventions · 2017 · 55 citations

Medicine, Cardiology, Pharmacotherapy +14

Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)

Athimalaipet V Ramanan, Catherine Guly, Stuart Keller et al. · Trials · 2021 · 55 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +17

Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study

Usman Baber, Samantha Sartori, Melissa Aquino et al. · American Heart Journal · 2017 · 33 citations

Medicine, Cardiology, Pharmacotherapy +17